We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
Out of stock
This item is currently unavailable
The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics
Price data last checked 39 day(s) ago - refreshing...
One email. No newsletter. No nudges.
Gone for 266 days. Could come back at any time — we're watching for you.
Out of stock 266 days · last price £795 · longest previous gap was 1 days
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 692 days · 692 data points (no recent data)
Price Distribution
Price distribution over 692 days • 1 price levels
Price Analysis
Most common price: £795 (692 days, 100.0%)
Price range: £795 - £795
Price levels: 1 different prices over 692 days
Product Specifications
- Format
- paperback
- ASIN
- B082JQ64KT
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 13 February 2020
- Listed Since
- 13 December 2019
Similar Products You Might Like
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States
The 2026-2031 World Outlook for Antidepressant Drugs
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China
The 2021-2026 World Outlook for Antidepressants
The 2026-2031 World Outlook for Antidepressant Pharmaceuticals
The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan
The 2026-2031 World Outlook for Antidepressants
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders for US Zip Codes
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders
Diagnostik und Verlauf depressiver Störungen: Differenzierung der Depression - Einbezug von Persönlichkeit und Temperament - multidimensionale Diagnostik
Recent Advances and Challenges in the Treatment of Major Depressive Disorder: 1456 (Advances in Experimental Medicine and Biology, 1456)
Springer
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation
Academic Press
The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants
Prevention and Early Treatment of Depression Through the Life Course (Depression and Personality)
Springer
Recent Advances in Depression: Complications, Awareness, and Management: (Mental Illnesses and Treatments Series)
Nova
Price unavailable
Translational Research Methods for Major Depressive Disorder: 179 (Neuromethods, 179)
Humana
Depressive Disorders: Integrated and Unified Psychotherapy Approaches
Routledge
Psychology and Phenomenology of Depression: 2 (Depression: Understanding the Silent Epidemic)
Depression: A Silent Culprit in Health and Disease
Bentham Science Publishers